1 月 11 日消息 百度宣布正式组建一家智能汽车公司，以整车制造商的身份进军汽车行业。吉利控股集团将成为新公司的战略合作伙伴。双方将基于吉利最新研发的浩瀚 SEA 智能进化体验架构，在智能汽车制造相关领域展开紧密合作，共同打造下一代智能汽车。

新组建的百度汽车公司将面向乘用车市场，着眼于智能汽车的设计研发、生产制造、销售服务全产业链，传承百度的人工智能、互联网科技基因，利用 Apollo 自动驾驶能力，发挥在汽车智能化领域长达 8 年的经验优势，重塑智能汽车产品形态，要做智能出行时代的变革者。

百度汽车公司独立于母公司体系，保持自主运营；同时百度将人工智能、Apollo 自动驾驶、小度车载、百度地图等核心技术全面赋能汽车公司，支持其快速成长。

下一步双方将基于吉利最新研发的全球领先纯电动架构 -- 浩瀚 SEA 智能进化体验架构，在智能汽车制造相关领域展开紧密合作，共同打造下一代智能汽车。

On January 9, Beijing time, the State Council’s Joint Prevention and Control Mechanism held a press conference. Zeng Yixin, deputy director of the National Health Commission, said that so far, my country has carried out nearly 9 million doses of new coronavirus vaccination, proving that my country's new coronavirus vaccine has good safety. In the next step, we will comprehensively and orderly promote the vaccination of high-transmission groups, high-risk groups and the general population, and implement free vaccination for all. Li Tao, deputy director of the National Medical Security Administration, said that the cost of vaccination will be borne by the medical insurance fund and finance, and residents will not bear the cost.

Sinopharm China Biosciences has started the large-scale production of the new crown vaccine. Each dose of vaccine has an electronic ID card that traces the flow of the vaccine throughout. Where the vaccine reaches and who is vaccinated will be recorded.

It is understood that the new crown vaccine packaging is divided into light inspection, rotary rod labeling, boxing, weighing, and coding systems to ensure the quality and safety of the vaccine.

Yang Xiaoming, Chairman of Sinopharm Group China Biotechnology, introduced that the regulatory code is equivalent to the "electronic ID card" of vaccines, which is divided into three levels: each vaccine is individually coded, every 10 vaccines is composed of a medium package code, and contains multiple medium packages The large package and then code.

Through the supervision code, you can check whether the vaccine production, warehousing, storage, delivery, transportation and other processes meet the standards, and track the person receiving the injection.

The size of my country's new crown vaccine market may be nearly 100 billion

China Securities Investment said that at this stage, orders for the new crown vaccine have been placed. According to the order volume, the country’s penetration rate is calculated. The United States, the United Kingdom, the European Union of four countries and Japan are respectively 100%, 100%, 65% and 100%. Taking into account the epidemic situation in my country Stable, but the world is still in the pandemic stage and my country is accompanied by repeated regional epidemics. It is estimated that the penetration rate of my country's new crown vaccine is generally assumed to be 60%, and the corresponding market size is about 84 billion yuan.

According to the agency, according to my country’s current clinical trial phase of the new crown vaccine project, according to the existing design capacity limit is about 1.8 billion doses, which can meet the demand of 900 million people. Considering the time required for the release of production capacity of some enterprises, it will be available in a short time. There are still gaps in the supply of new crown vaccine projects to the domestic and developing markets.

根据新华社的消息，有“中国天眼”之称的 500 米口径球面射电望远镜（FAST）将于 2021 年 4 月 1 日正式对全球科学界开放，8 月 1 日起分配观测时间，预计分配给国外科学家的观测时间约占 10%。

500 米口径球面射电望远镜（Five-hundred-meter Aperture Spherical radio Telescope）利用贵州喀斯特地区的洼坑作为望远镜台址建造的世界第一大单口径射电望远镜，其拥有 30 个标准足球场大的接收面积。FAST 作为世界最大的单口径望远镜，将在未来 20 至 30 年保持世界一流地位。全新的设计思路，加之得天独厚的台址优势，使其突破了望远镜的百米工程极限，开创了建造巨型射电望远镜的新模式。

去年 11 月公布的数据显示，中国天眼 FAST 已发现脉冲星数量超过 240 颗，基于 FAST 数据发表的高水平论文达到 40 余篇。

这个患者目前已经核酸转阴离开隔离病房了

1月1日晚，上海复旦大学附属华山医院感染科主任张文宏在其个人微博发文称，上海疾控检测到第一株VOC毒株，立即向中国疾控申报，并且在中国疾控的官方杂志China CDC Weekly （中国疾控周报）上向全球发布，“这是一个常规动作，证明对于变异病毒株中国目前具备非常强的监测能力”。

张文宏医生在其博文中表示：“这个病例其实没有任何特殊，和任何一个感染了新冠病毒肺炎的其他患者没有区别。”

此外为了打消大家的疑虑。张文宏医生特地去翻看了这个患者的病历，因为没有任何特殊，所以原来根本就没有注意。“这个病例的症状非常轻微，轻微到不需要我关注。这个患者目前已经核酸转阴，离开隔离病房了。”

中国疾控中心：目前英国报道的新冠病毒变异株致病性尚无明显变化 不必恐慌.

上海发现的变异株在人群中的传播力增强了吗？

上海发现的变异株基因检测结果表明变异株对细胞感染力增强，但在人间传播力与人类社会活动、冬季的气候和人群的自我防护措施紧密相关。

该变异株致病毒力和严重性增强了么？

目前新冠病毒变异株与既往变异株的致病性、严重性或者病死率未见差异，致病性尚无明显变化，不必恐慌。

我国新冠疫苗是否对变异株有保护作用吗？

目前尚未发现新冠病毒变异株对我国上市的灭活新冠疫苗的免疫效力产生影响。

我国新冠疫苗核酸检测试剂能否检出变异株？

目前我国主流核酸诊断试剂是针对的新冠病毒双靶标基因、N基因和ORF1ab基因，蛋白基因变异不影响核酸试剂的敏感性和特异性，上海变异株就是我国本土核酸试剂检测出来的。

我国现有防控新冠病毒传播的措施是否有效？

我国4月份阻断了本土新冠病毒的传播，之后通过境外输入的病例或污染的冷链物品导致的10多起新冠病毒肺炎聚集性疫情，都采取了有效的阻断传播措施。定期筛查高风险人群、早诊断、早治疗、早期隔离感染者和密接者，戴口罩，勤洗手，保持社交距离；是我国行之有效的阻断新冠病毒传播的有效措施。

针对新冠病毒变异株的出现，应该进一步采取什么措施？

百姓不必恐慌，一定要严格落实我国现有防控措施，需要加强个人防护意识，特别是加强针对有输入病例的医院或定点隔离酒店的医护和从业人员的防护。